| Literature DB >> 34770868 |
Kayo Horie1, Hayato Maeda2, Naoki Nanashima1, Indrawati Oey3,4.
Abstract
Polyphenols are bioactive compounds found naturally in fruits and vegetables; they are widely used in disease prevention and health maintenance. Polyphenol-rich blackcurrant extract (BCE) exerts beneficial effects on vascular health in menopausal model animals. However, the vasculoprotective effects in diabetes mellitus (DM) and atherosclerotic vascular disease secondary to DM are unknown. Therefore, we investigated whether BCE is effective in preventing atherosclerosis using KK-Ay mice as a diabetes model. The mice were divided into three groups and fed a high-fat diet supplemented with 1% BCE (BCE1), 3% BCE (BCE2), or Control for 9 weeks. The mice in the BCE2 group showed a considerable reduction in the disturbance of elastic lamina, foam cell formation, and vascular remodeling compared to those in the BCE1 and Control groups. Immunohistochemical staining indicated that the score of endothelial nitric oxide synthase staining intensity was significantly higher in both BCE2 (2.9) and BCE1 (1.9) compared to that in the Control (1.1). Furthermore, the score for the percentage of alpha-smooth muscle actin was significantly lower in the BCE2 (2.9%) than in the Control (2.1%). Our results suggest that the intake of anthocyanin-rich BCE could have beneficial effects on the blood vessels of diabetic patients.Entities:
Keywords: alpha-smooth muscle actin (α-SMA); blackcurrant extract; diabetes model animal; endothelial nitric oxide (eNOS); polyphenol
Mesh:
Substances:
Year: 2021 PMID: 34770868 PMCID: PMC8587626 DOI: 10.3390/molecules26216459
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Representative images of foam cell uptake in the tunica intima obtained using Elastica van Gieson staining in the Control (high-fat diet without BCE), BCE1 (high-fat diet supplemented with 1% BCE powder), and BCE2 (high-fat diet supplemented with 3% BCE powder) groups. (A) Lower magnification image (100×, scale bar = 50 µm) and (B) higher magnification image of the boxed areas shown in panel A (magnification 400×, scale bar = 20 µm).
Figure 2Immunohistochemical staining of eNOS in the Control (high-fat diet without BCE), BCE1 (high-fat diet supplemented with 1% BCE powder), and BCE2 (high-fat diet supplemented with 3% BCE powder) groups. (A) eNOS expression at a lower magnification (200×, scale bar = 20 µm). (B) A higher magnification image of the boxed areas shown in panel A (400×, scale bar = 20 µm). (C) Scoring of staining intensity of eNOS. Data are expressed as the mean score ± standard error. * p < 0.05, ** p < 0.01.
Figure 3Immunohistochemical staining of α-SMA in the Control (high-fat diet without BCE), BCE1 (high-fat diet supplemented with 1% BCE powder), and BCE2 (high-fat diet supplemented with 3% BCE powder) groups. (A) α-SMA expression at a lower magnification (200×, scale bar = 20 µm). (B) A higher magnification of the boxed areas shown in panel A (400×, scale bar = 20 µm). (C) Scoring of the percentage of α-SMA-positive cells in the tunica intima of the specimens from each group. Data are expressed as the mean score ± standard error. * p < 0.05.